Evidence map›Paper›PMID 28739912›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2017

The critical phase for visual control of human walking over complex terrain.

Jonathan Samir Matthis, Sean L Barton, Brett R Fajen

Abstract readClinical Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Altered walking gaze behavior after stroke: more than meets the eye.Journal of neuroengineering and rehabilitation · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jonathan Samir MatthisCenter for Perceptual Systems, University of Texas at Austin, Austin, TX 78712; matthis@utexas.edu.
Sean L BartonCognitive Science Department, Rensselaer Polytechnic Institute, Troy, NY 12180.
Brett R FajenCognitive Science Department, Rensselaer Polytechnic Institute, Troy, NY 12180.

Funding

The Visual Guidance of LocomotionR01EY019317 · NEI · RENSSELAER POLYTECHNIC INSTITUTE · PI FAJEN, BRETT R · 2009 to 2012
$743k
NEI NIH HHS R01 EY019317
6 · The paper itself

Abstract

To walk efficiently over complex terrain, humans must use vision to tailor their gait to the upcoming ground surface without interfering with the exploitation of passive mechanical forces. We propose that walkers use visual information to initialize the mechanical state of the body before the beginning of each step so the resulting ballistic trajectory of the walker's center-of-mass will facilitate stepping on target footholds. Using a precision stepping task and synchronizing target visibility to the gait cycle, we empirically validated two predictions derived from this strategy: (1) Walkers must have information about upcoming footholds during the second half of the preceding step, and (2) foot placement is guided by information about the position of the target foothold relative to the preceding base of support. We conclude that active and passive modes of control work synergistically to allow walkers to negotiate complex terrain with efficiency, stability, and precision.

Indexed as

AdolescentAdultFemaleHumansMaleVisual PerceptionWalkingbiomechanicsfoot placementhuman locomotioninverted pendulumvisual control

Identifiers

PMID28739912
PMCPMC5558990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.